Celltrion to develop oral autoimmune disease treatment with US firm
Celltrion, a leading biopharmaceutical company in South Korea, has partnered with Rani Therapeutics, a US-based clinical-stage biotech company. According to ...
Celltrion, a leading biopharmaceutical company in South Korea, has partnered with Rani Therapeutics, a US-based clinical-stage biotech company. According to ...
Celltrion HealthcareĀ announced on Wednesday that it would commence clinical trials of Remsima, an anti-inflammatory biosimilar, on COVID-19 patients this month ...
Bioneer Co., a South Korean biotech firm, on Wednesday, said that it signed a memorandum of understanding (MOU) to source ...
Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...
Copyright Ā© 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |